Viveon Health Acquisition Corp.: 10-K/A filed 2024-02-21

Name: Viveon Health Acquisition Corp.: 10-K/A filed 2024-02-21
Creator: Viveon Health Acquisition Corp.

What Viveon Health Acquisition Corp. reported in its annual report amendment filed 2024-02-21 (fiscal FY 2022): 30 published measures, 87 facts as tagged in accession 0001493152-24-007415.

This is an amendment. Values here are as tagged in the amendment; the original filing has its own page.

This filing

Form: 10-K/A (annual report amendment)
Filed: 2024-02-21
Fiscal period: fiscal FY 2022
Accession: 0001493152-24-007415 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Viveon Health Acquisition Corp. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2022-12-31	53,923,227	USD
At 2021-12-31	203,697,087	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit
At 2022-12-31	50,708,170	USD
At 2022-09-30	19,039,027	USD
At 2022-06-30	16,795,594	USD
At 2022-03-31	17,442,024	USD
At 2021-12-31	13,420,403	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2022-12-31	-16,198,822	USD
At 2022-09-30	-18,393,299	USD
At 2022-06-30	-15,176,383	USD
At 2022-03-31	-15,314,010	USD
At 2021-12-31	-12,985,816	USD
At 2020-12-31	-15,607,036	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit	Days
At 2022-12-31	19,847	USD
At 2021-12-31	395,235	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	-605,294	USD	365
2022-07-01 to 2022-09-30	-2,478,491	USD	92
2022-01-01 to 2022-09-30	-3,709,058	USD	273
2022-04-01 to 2022-06-30	377,627	USD	91
2022-01-01 to 2022-06-30	-1,230,567	USD	181
2022-01-01 to 2022-03-31	-1,608,194	USD	90
2021-01-01 to 2021-12-31	2,489,829	USD	365

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	-1,753,388	USD	365
2021-01-01 to 2021-12-31	-2,082,334	USD	365

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	-148,813,819	USD	365
2021-01-01 to 2021-12-31	-619,387	USD	365

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	150,191,819	USD	365

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit
At 2022-12-31	-16,199,325	USD
At 2022-09-30	-18,393,802	USD
At 2022-06-30	-15,176,886	USD
At 2022-03-31	-15,314,513	USD
At 2021-12-31	-13,143,459	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	12,224,223	shares	365
2021-01-01 to 2021-12-31	24,150,000	shares	365

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	12,224,223	shares	365
2021-01-01 to 2021-12-31	24,150,000	shares	365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	-0.05	USD/shares	365
2022-07-01 to 2022-09-30	-0.27	USD/shares	92
2022-01-01 to 2022-09-30	-0.28	USD/shares	273
2022-04-01 to 2022-06-30	0.04	USD/shares	91
2022-01-01 to 2022-06-30	-0.08	USD/shares	181
2021-01-01 to 2021-12-31	0.1	USD/shares	365

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	-0.05	USD/shares	365
2022-07-01 to 2022-09-30	-0.27	USD/shares	92
2022-01-01 to 2022-09-30	-0.28	USD/shares	273
2022-04-01 to 2022-06-30	0.04	USD/shares	91
2022-01-01 to 2022-06-30	-0.08	USD/shares	181
2021-01-01 to 2021-12-31	0.1	USD/shares	365

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	61,310	USD	365

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2021-01-01 to 2021-12-31	157,140	USD	365

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	-2,489,807	USD	365
2022-07-01 to 2022-09-30	-1,033,369	USD	92
2022-01-01 to 2022-09-30	-2,927,333	USD	273
2022-04-01 to 2022-06-30	-736,007	USD	91
2022-01-01 to 2022-06-30	-1,893,964	USD	181
2022-01-01 to 2022-03-31	-1,157,957	USD	90
2021-01-01 to 2021-12-31	-4,105,787	USD	365

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2022-12-31	68,573	USD
At 2021-12-31	414,098	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	3,645,777	USD	365

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit
At 2022-12-31	41,028,336	USD
At 2022-09-30	4,767,300	USD
At 2022-06-30	3,461,687	USD
At 2022-03-31	3,295,434	USD
At 2021-12-31	2,188,432	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2022-12-31	226,796	USD
At 2021-12-31	47,720	USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	152,451,819	USD	365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2022-12-31	5,031,250	shares
At 2021-12-31	5,031,250	shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

Period	Value	Unit
At 2022-12-31	19,847	USD
At 2021-12-31	395,235	USD
At 2020-12-31	3,096,956	USD

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2021-12-31	157,140	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit
At 2022-12-31	2,269,218	USD
At 2022-09-30	3,134,027	USD
At 2022-06-30	2,648,026	USD
At 2022-03-31	2,698,491	USD
At 2021-12-31	1,927,662	USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

Period	Value	Unit	Days
At 2022-12-31	39,259	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	-543,984	USD	365
2021-01-01 to 2021-12-31	2,489,829	USD	365

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	1,945,823	USD	365
2021-01-01 to 2021-12-31	6,595,616	USD	365

Deferred income tax expense or benefit

The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	-39,259	USD	365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2022-01-01 to 2022-12-31	179,076	USD	365
2021-01-01 to 2021-12-31	47,720	USD	365

Inspect the source

Entity: Viveon Health Acquisition Corp. / CIK 0001823857
Captured: 2026-09-23 03:04 UTC
SEC response SHA-256: 13200abe5802922ca83e04024b6a21dfc965295a0128a62c3589913a4ecb87c4

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001823857.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))